Compare AbbVie Inc (ABBV) vs Synchrony Financial (SYF) Price & Performance

AbbVie IncTrade

Synchrony FinancialTrade

Price performance (Past 24H)

Key statistics

AbbVie Inc vs Synchrony Financial — how do they compare? AbbVie Inc trades at $249.84 (market cap $441.94B), while Synchrony Financial trades at $78.37 (market cap $25.53B). The key difference: AbbVie Inc is far larger — about 17.3× Synchrony Financial's market cap, and AbbVie Inc pays the higher dividend (2.77%). Which is the better fit depends on your goals.

	ABBV	SYF
Market Cap	$441.94B	$25.53B
Sector	Health	Financials
52-Week High	$263.58	$88.47
52-Week Low	$197.38	$63.78
Enterprise Value	$506.19B	—
Dividend Yield	2.77%	1.73%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AbbVie Inc

ABBV trades at $247.91, up 0.76% today, with a bullish technical signal supported by moving averages and oversold RSI levels. The company reported Q2 2026 EPS of $3.65, beating expectations, and maintains strong profitability with a 71.48% gross margin. Recent news highlights positive Phase 2 data for ELAHERE in ovarian cancer, reinforcing growth prospects beyond Humira's patent expiry.

Outlook is positive with analyst consensus target of $278.69, though high P/E of 70.05 and debt levels pose valuation and financial risks. Revenue growth driven by Skyrizi and Rinvoq offsets competitive pressures, but patent cliffs in the 2030s require monitoring. The stock offers dividend appeal with a $1.73 payout scheduled for August 2026.

Synchrony Financial

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ABBV

Fidelity Dividend ETF's payout is safe but not ideal for steady income due to variable quarterly dividends.24/7 Wall Street · 22 hours agoNeutral Two Dividend Aristocrats outperformed the market while two lagged; three new picks show promising dividend growth.24/7 Wall Street · 2 days agoNeutral Healthcare sector leads S&P 500 gains over 3 months with key pharma stocks showing strong innovation and income potential.24/7 Wall Street · 2 days agoBullish View details →

SYF

Special financing now available for PayPal Credit Card on entire Mastercard networkPYMNTS · 1 day agoBullish View details →

About AbbVie Inc

AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

About Synchrony Financial

Synchrony Financial is a premier consumer financial services company and the largest provider of private-label credit cards in the United States. Spun off from GE Capital in 2014, it operates through a unique B2B2C model, embedding its financing products within the ecosystems of major partners like Amazon, Lowe’s, and PayPal. Synchrony leverages deep data analytics and a diverse multi-platform strategy—spanning retail, health, and auto—to drive customer loyalty and provide specialized credit solutions at the point of sale.